My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Rispoval IBR-Marker Live



Zoetis Belgium S.A.VPA10387/062/001

Main Information

Trade NameRispoval IBR-Marker Live
Active SubstancesBovine herpes virus type 1 (BHV-1), strain difivac (gE-negative), modified live (attenuated) virus
Dosage FormLyophilisate and solvent for suspension for injection
Licence HolderZoetis Belgium S.A.
License Holder Address2nd Floor, Building 10
Cherrywood Business Park, Loughlinstown
Co Dublin
Ireland
Licence NumberVPA10387/062/001

Group Information

ATC CodeQI02AD01 bovine rhinotracheitis virus (IBR)
Therapeutic ClassImmunological - Live Vaccine
SpeciesCattle

Status

License statusAuthorised
Licence Issued09/12/2013
Legal StatusPOM (E): Prescription Only Exempt as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back
Follow medicine

Print